Senseonics Holdings, Inc. (SENS) Stock Profile — Insider Trades & Financials

Revenue$14.3M

Net Income-$20.8M

EPS$-1.66

Gross Margin53.8%

Market Cap$279.0M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Timothy Goodnow

CEO & Executive Director

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Founded: 1996
Employees: 130
Headquarters

⚡

Core Efficiency

ROE?

-34.11%

ROA?

-16.49%

D/E Ratio?

1.07

Op. Margin?

-146.78%

📊

Profitability Ratios

Net Margin?

-146.06%

Loading company sections...

Senseonics Holdings, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness